148P: Concordance between detection of EGFR mutations on tissue and in circulating free tumor DNA (cftDNA) in newly diagnosed metastatic lung adenocarcinoma (mLA).

@article{Veccia2016148PCB,
  title={148P: Concordance between detection of EGFR mutations on tissue and in circulating free tumor DNA (cftDNA) in newly diagnosed metastatic lung adenocarcinoma (mLA).},
  author={Antonello Veccia and Orazio Caffo and Salvatore Girlando and Silvia Fasanella and Mariachiara Dipasquale and Viviana Murgia and Mattia Barbareschi and Enzo Galligioni},
  journal={Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer},
  year={2016},
  volume={11 4 Suppl},
  pages={S122}
}
147P Level of concordance between EGFR mutation status obtained from tissue/cytology and blood (plasma) for advanced non-small-cell lung cancer in Spain: ASSESS study E. Arriola1, A. Paredes2, R. Garcı́a Gomez3, P. Diz4, M. Constenla5, C. Garcı́a Girón6, M. Amador7, M. Reck8, G. López Vivanco9. 1 Cancer Sciences Unit, Southampton General Hospital Southampton University Hospitals NHS Trust, Southampton, UK , 2 Servicio de Oncologı́a Médica, Hospital Donostia, San Sebastian, Spain, 3 Servicio de… CONTINUE READING